Cornerstone Enterprises’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cornerstone Enterprises’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.46M	Buy	+9,262	New	+$1.46M	0.85%	23

Other funds holding XBI

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.78% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

Cornerstone Enterprises's XBI Position: Q3 2026 in Review

Cornerstone Enterprises opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 9,262 shares worth $1.46M. The stake represents 0.85% of the portfolio and ranks #23 among its holdings.

143 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Cornerstone Enterprises held 9,262 shares of State Street SPDR S&P Biotech ETF worth $1.46M as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Cornerstone Enterprises position in Q3 2026.
State Street SPDR S&P Biotech ETF made up 0.85% of Cornerstone Enterprises's portfolio in Q3 2026, its #23 holding.
143 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Cornerstone Enterprises's 13F filing for Q3 2026, filed 15 Oct 2026.